Aivocode, LLP
Publicly observedEncinitas, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Encinitas | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Aivocode, LLP | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | TLPZZJEMNND1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant16 Sept 2026Publicly observed
NIH SBIR/STTR award: Early Detection of Alzheimer’s Disease Using a Novel ImmunoPET Conjugate
USD 499,880.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2025Publicly observed
NIH SBIR/STTR award: Single domain antibody development for improving vascular dysfunction in Alzheimer’s disease
USD 1,237,522.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2025Publicly observed
NIH SBIR/STTR award: Single domain antibody development for improving vascular dysfunction in Alzheimer’s disease
USD 1,244,775.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant3 Feb 2025Publicly observed
NIH SBIR/STTR award: Development of a novel peptide therapeutic for traumatic brain injury
USD 87,001.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.